NCT05972486

Brief Summary

The purpose of this study is to see if it is feasible for midlife women to wear a brain activity sensing headband (Muse-S) for management of sleep disturbances such as insomnia and sleep disruption

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 2, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2025

Completed
1 year until next milestone

Results Posted

Study results publicly available

January 26, 2026

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1.5 years

First QC Date

July 25, 2023

Results QC Date

January 8, 2026

Last Update Submit

January 8, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Quality of Sleep

    Measured using the self-reported Pittsburgh Sleep Quality Index (PSQI) to assess the severity of sleep disturbances. Possible scores range from 0 to 21 with higher scores indicating a worse outcome/more severe symptoms of sleep disturbance.

    Baseline, 3 months, 6 months

  • Sleep Impact

    Measured using the self-reported ASCQ-Me Sleep Impact Short Form. The 5-item questionnaire used to assess functioning and wellbeing in accordance with sleep. The questions in this assessment tool ask how often they felt sleep impacted specific activities during the the past 7 days. Possible answers include: 5 - never; 4 - rarely; 3 - sometimes; 2 - often, and 1 - always. Possible scores range from 5 to 25, with higher scores indicating a better outcome.

    Baseline, 3 months, 6 months

Secondary Outcomes (5)

  • Perceived Stress Levels

    Baseline, 3 months, 6 months

  • Change in Perceived Anxiety

    Baseline, 3 months, 6 months

  • Sexual Function

    Baseline, 3 months, 6 months

  • Sexual Distress

    Baseline, 3 months, 6 months

  • Change in Quality of Life

    Baseline, 3 months, 6 months

Study Arms (1)

Muse-S headband system for management of sleep disturbances

EXPERIMENTAL

Study participants will receive a new Muse-S headband system at study entry and will be asked to utilize it daily for a minimum of 10 minutes day for a period of 6 months (24 weeks). Three of the seven sessions per week will specifically be asked to be mind meditation.

Device: Muse-S™ headband system

Interventions

Clinical grade, headband-style wireless EEG (electroencephalogram is a test used to evaluate the electrical activity in the brain) system and designed to interact with a mobile device (a smartphone or tablet). The device is a soft, stretchy band that fits around the forehead to the back of the head.

Muse-S headband system for management of sleep disturbances

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women in the menopause transition or in menopause, based on clinical assessment
  • PSQI score \> 5, with overall sleep quality rating of "fairly bad" or "very bad".
  • Motivation VAS score equal to or greater than 5 with overall motivation rating of on a scale of 0-10 with 0 being not motivated at all and 10 being extremely motivated.
  • Access to an iPad, iPhone, or android device.
  • Have ability to provide informed consent.

You may not qualify if:

  • Suspected or untreated obstructive sleep apnea.
  • Moderate to severe vasomotor symptoms warranting prescription medication use. The FDA categories for hot flash severity are classified as mild (sensation of heat without sweating), moderate (sensation of heat with sweating, able to continue activity), or severe (sensation of heat with sweating cause cessation of activity).
  • Use of hormone therapy or hypnotic agents.
  • Use of supplements known to affect sleep.
  • A known, active, untreated clinically significant psychiatric condition.
  • Use of an investigational drug within 30 days of study enrollment or presence of a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.
  • Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic Minnesota

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersParasomnias

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Results Point of Contact

Title
Amber Klindworth, P.A.-C.
Organization
Mayo Clinic

Study Officials

  • Amber Klindworth, PA-C

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 25, 2023

First Posted

August 2, 2023

Study Start

August 1, 2023

Primary Completion

January 12, 2025

Study Completion

January 12, 2025

Last Updated

January 26, 2026

Results First Posted

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations